Kevin Johnston
Chief Tech/Sci/R&D Officer presso CULLINAN THERAPEUTICS, INC.
Profilo
Attualmente Kevin A. Johnston occupa la posizione di Chief Technical Officer & Vice President presso Reata Pharmaceuticals, Inc. Johnston è stato in precedenza direttore senior dello sviluppo analitico presso Collegium Pharmaceutical, Inc., direttore associato dello sviluppo farmaceutico presso Praecis Pharmaceuticals, Inc., vicepresidente della catena di fornitura e logistica presso Tesaro, Inc. e direttore di Charles River Laboratories Edinburgh Ltd. Johnston si è laureato alla Northeastern University e si è laureato al Lafayette College.
Posizioni attive di Kevin Johnston
Società | Posizione | Inizio |
---|---|---|
CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Precedenti posizioni note di Kevin Johnston
Società | Posizione | Fine |
---|---|---|
REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
TESARO INC | Corporate Officer/Principal | 01/05/2020 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Charles River Laboratories Edinburgh Ltd.
Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Charles River Laboratories Edinburgh Ltd. provides drug development services. The company is headquartered in Tranent, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Kevin Johnston
Lafayette College | Undergraduate Degree |
Northeastern University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
CULLINAN THERAPEUTICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Charles River Laboratories Edinburgh Ltd.
Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Charles River Laboratories Edinburgh Ltd. provides drug development services. The company is headquartered in Tranent, the United Kingdom. | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
- Borsa valori
- Insiders
- Kevin Johnston